Rodman & Renshaw maintained its Stryker SYK Market Perform rating in a research report published today.
In the report, Rodman & Renshaw states, "Stryker reported Q2 numbers yesterday with revenues coming in at $2.05 billion and adjusted EPS of $0.90. Core recon revenues did not inspire, and growth primarily was delivered by contribution from OUS, MedSurg, and acquisitions."
Shares of Stryker closed today at $56.91, down 3.80% from Tuesday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in